Abstract
Familial clustering of thrombosis suggests that genetic risk factors are important in the pathogenesis of venous thromboembolism. However, until recently, well defined genetic defects such as antithrombin, protein C and protein S deficiencies accounted for less than 10% of patients with thrombosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dahlback, B., Carlsson, M., and Svensson, P. J. (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA 90, 1004–1008.
Koster, T., Rosendaal, F.R., de Ronde, H., Briet, F., Vandenbroucke, J.P., and Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C:Leiden thrombophilia study. Lancet 342, 1503–1506.
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P., A., and Reitsma, P. H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67.
Kalafatis, M., Bertina, R. M., Rand, M. D., and Mann, K. G. (1995) Characterisation of the molecular defect in factor V R506Q. J. Biologic. Chem. 270, 4053–4057.
Halbmeyer, W-M., Haushofer, A., Schon, R., and Fischer, M. (1994) The prevalence of poor anticoagulant response to activated protein C resistance (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul. Fibrinolysis 5, 51–57.
Beauchamp, N. J., Daly, M. E., Hampton, K. K., Cooper, P. C., Preston, F. E., and Peake, I. R. (1994) High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br. J. Haematol. 88, 219–222.
Rees, D. C., Cox, M., and Clegg, J. B. (1995) World distribution of factor V Leiden. Lancet Oct 28;346,(8983), 1133–1134.
De-Stefano, V. and Leone, G. (1995) Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia. Haematologica 80(4), 344–356.
Nowak-Gottl, U., Koch, H.G., Aschka, I., Kohlhase, B., Vielhaber, H., Kurlemann, G., Oleszcuk-Raschke, K., Kehl, H. K., Jurgens, H., and Schneppenheim, R. (1996) Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br. J. Haematol. Mar;92(4), 992–998.
Dahlback, B. (1995) New molecular insights in to the genetics of thrombophilia. Resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb. Haemostasis Jul;74(1), 139–148.
Ridker, P. M., Miletich, J. P., Stampfer, M. J., Goldhaber, S. Z., Lindpaintner, K., and Hennekens, C. H. (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation Nov 15;92(10), 2800–2802.
Greengard, J. S., Eichinger, S., Griffin, J.H., and Bauer, K. A. (1994) Briefreport: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg to Gln mutation in the gene of factor V. N. Engl. J. Med. 331, 1559–1562.
Beauchamp, N. J., Daly, M. E., Cooper, P. C., Preston, F. E., and Peake, I. R. (1994) Rapid two-stage PCR for detecting factor V G1691A mutation. Lancet 344, 694–695.
Rabes, J. P., Trossaert, M., Conard, J., Samama, M., Giraudet, P., and Boileau, C. (1995) Single point mutation at Arg 506 of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis. Thromb. Haemostasis Nov;74(5), 1379–1380.
van-de-Locht, L. T., Kuypers, A. W., Verbruggen, B. W., Linssen, P. C., Novakova, I. R., and Mensink, E. J. (1995) Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb. Haemostasis Nov;74(5), 1276–1279.
Gandrille, S., Alhenc-Gelas, M., and Aiach, M. (1995) A rapid screening method for the factor V Arg 506 to Gln mutation. Blood Coagul. Fibrinolysis 6, 245–248.
Bell, G. I., Karman, J. H., and Rutter, W. J. (1981) Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc. Natl. Acad. Sci. USA 78(9), 5759–5763.
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, J. T., Erlich, H. A., and Arnheim, N. (1985) Enzymatic amplification of the β-globin genomic sequences and restriction site analysis for the diagnosis of sickle cell anaemia. Science 230, 1350–1354.
Cripe, L. D., Moore, K. D., and Kane, W. H. (1992) Structure of the gene for human coagulation factor V. Biochemistry 31, 3777–3785.
Gitschier, J., and Wood, W. I. (1992) Sequence of exon-containing regions of the human factor V gene. Human Mol. Genet. 1, 199,200.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Brown, K.P. (1999). Screening for the Factor V Leiden Mutation. In: Perry, D.J., Pasi, K.J. (eds) Hemostasis and Thrombosis Protocols. Methods in Molecular Medicine™, vol 31. Humana Press. https://doi.org/10.1385/1-59259-248-1:275
Download citation
DOI: https://doi.org/10.1385/1-59259-248-1:275
Publisher Name: Humana Press
Print ISBN: 978-0-89603-419-8
Online ISBN: 978-1-59259-248-7
eBook Packages: Springer Protocols